Resveratrol promotes neurotrophic factor release from astroglia

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Neurotrophic factors, including glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF), are crucial for neuronal and glial cell health.
• Astroglia are significant producers of these neurotrophic factors, making them a potential target for therapeutic interventions.
• Resveratrol, a polyphenol from grapes and red wine, exhibits health benefits, prompting investigation into its effects on neurotrophic factor release.

Purpose of the Study:

• To investigate the impact of resveratrol on neurotrophic factor release from primary rat astroglia.
• To elucidate the underlying molecular mechanisms, specifically the involvement of signaling pathways like ERK1/2 and CREB.

Main Methods:

• Primary rat astroglia-enriched cultures were treated with varying concentrations of resveratrol (25-100 μmol/L) for 12-48 hours.
• Quantification of BDNF and GDNF levels in the culture medium using established assays.
• Western blot analysis was performed to assess protein levels and phosphorylation status of ERK1/2 and CREB.

Main Results:

• Resveratrol significantly increased the production of both BDNF and GDNF in the astroglia culture medium.
• BDNF levels showed a five-fold increase within 24 hours, while GDNF levels increased up to six-fold by 36 hours post-treatment.
• Resveratrol induced the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and cAMP responsive element-binding protein (CREB) in astroglia.

Conclusions:

• Resveratrol effectively promotes the release of astroglia-derived neurotrophic factors, BDNF and GDNF.
• The observed increase in neurotrophic factor release is, at least partially, mediated by the activation of the ERK1/2 and CREB signaling pathways.
• These findings suggest resveratrol as a potential therapeutic agent for neurological conditions by enhancing neurotrophic support.